enhanced lung function | Steris Healthcare Pvt Ltd, Mumbai

Mumbai 08042755542 info@sterispharma.com

Chat with us

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

{ "products": [ { "_id": "6a685f3a5315456e18559082", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Acebrophylline and Erdosteine Tablets", "description": "Acebrophylline and Erdosteine Tablets are a clinically trusted combination used in the management of chronic respiratory disorders associated with excessive mucus production, airway inflammation, and breathing difficulties. This dual-action formulation combines the bronchodilator and anti-inflammatory properties of Acebrophylline with the mucolytic and antioxidant benefits of Erdosteine, making it an effective treatment option for patients suffering from chronic obstructive pulmonary disease (COPD), chronic bronchitis, bronchial asthma, and other mucus-related respiratory conditions.\n\nAt [Your Company Name], we manufacture and supply premium-quality Acebrophylline and Erdosteine Tablets that comply with WHO-GMP standards and international pharmaceutical quality guidelines. Our formulations are trusted by healthcare professionals, hospitals, distributors, and pharmaceutical companies seeking reliable respiratory medicines.\n\nComposition\nEach film-coated tablet typically contains:\n\nAcebrophylline – 200 mg\nErdosteine – 300 mg\nComposition can be customized based on customer requirements and regulatory approvals.\n\nHow Acebrophylline and Erdosteine Tablets Work\nThe combination provides comprehensive respiratory support through complementary mechanisms.\n\nAcebrophylline\nAcebrophylline acts as a bronchodilator and anti-inflammatory agent. It helps relax bronchial muscles, widens the airways, improves airflow, and reduces inflammation, making breathing easier for patients with chronic respiratory diseases.\n\nErdosteine\nErdosteine is a powerful mucolytic agent that reduces the thickness and stickiness of mucus. It facilitates easier expectoration, reduces coughing, and provides antioxidant protection against airway damage caused by inflammation.\n\nTogether, these ingredients improve lung function, reduce respiratory symptoms, and enhance patient comfort.\n\nKey Benefits of Acebrophylline and Erdosteine Tablets\nHelps improve breathing by relaxing bronchial muscles\nEffectively reduces thick mucus accumulation\nSupports easier mucus clearance from the lungs\nReduces chronic cough and chest congestion\nHelps manage COPD and chronic bronchitis symptoms\nProvides antioxidant protection to respiratory tissues\nImproves oxygen exchange and lung function\nEnhances quality of life in patients with chronic respiratory disorders\nSuitable for long-term respiratory disease management under medical supervision\nMedical Uses of Acebrophylline and Erdosteine Tablets\nHealthcare professionals commonly prescribe Acebrophylline and Erdosteine Tablets for:\n\nChronic Obstructive Pulmonary Disease (COPD)\nChronic Bronchitis\nBronchial Asthma\nRespiratory Tract Infections with Excessive Mucus\nChronic Productive Cough\nAirway Inflammation\nBronchiectasis\nSmoking-related Respiratory Conditions\nThese tablets should always be used under the supervision of a qualified healthcare professional.\n\nAdvantages of the Acebrophylline and Erdosteine Combination\nThe combination therapy offers several clinical advantages over single-drug treatment.\n\nDual Mechanism of Action\nIt simultaneously opens the airways while reducing mucus thickness, providing comprehensive respiratory relief.\n\nImproved Lung Function\nPatients experience better airflow and enhanced breathing comfort due to bronchodilation and mucus clearance.\n\nReduced Frequency of Exacerbations\nRegular use, as prescribed, may help decrease episodes of worsening respiratory symptoms in chronic lung diseases.\n\nBetter Patient Compliance\nA fixed-dose combination simplifies treatment by reducing the need for multiple medications.\n\nRecommended Dosage\nThe dosage of Acebrophylline and Erdosteine Tablets should be determined by a registered healthcare provider based on the patient's age, condition, and medical history.\n\nGeneral recommendations include:\n\nTake the tablet after meals with water.\nSwallow whole without crushing or chewing.\nFollow the prescribed duration of therapy.\nDo not exceed the recommended dose.\nPossible Side Effects\nLike all medicines, Acebrophylline and Erdosteine Tablets may cause side effects in some individuals.\n\nCommon side effects include:\n\nNausea\nStomach discomfort\nHeadache\nDizziness\nMild diarrhea\nDry mouth\nGastric irritation\nSeek immediate medical attention if severe allergic reactions, breathing difficulty, or persistent adverse effects occur.\n\nPrecautions\nBefore using Acebrophylline and Erdosteine Tablets, patients should inform their healthcare provider if they have:\n\nLiver disease\nKidney impairment\nGastric ulcer\nHeart disease\nPregnancy or breastfeeding\nKnown allergy to methylxanthines or Erdosteine\nAvoid self-medication and always follow professional medical advice.\n\nStorage Instructions\nStore below 25°C in a cool and dry place.\nProtect from direct sunlight and moisture.\nKeep out of reach of children.\nDo not use after the expiry date.\nWhy Choose Our Acebrophylline and Erdosteine Tablets?\nWe are committed to delivering pharmaceutical products that meet international quality standards.\n\nOur advantages include:\n\nWHO-GMP Certified Manufacturing\nISO Certified Production Facilities\nStringent Quality Control\nDCGI-Compliant Manufacturing\nCompetitive Pricing\nBulk Supply Capability\nThird-Party Manufacturing Services\nPrivate Label Packaging\nTimely Global Deliveries\nCustom Packaging Solutions\nWe serve pharmaceutical distributors, hospitals, government tenders, exporters, wholesalers, and healthcare institutions worldwide.\n\nFrequently Asked Questions (FAQs)\n1. What are Acebrophylline and Erdosteine Tablets used for?\nAcebrophylline and Erdosteine Tablets are primarily used to treat respiratory conditions such as COPD, chronic bronchitis, asthma, and other diseases associated with excessive mucus production and airway obstruction.\n\n2. How do Acebrophylline and Erdosteine Tablets work?\nAcebrophylline relaxes the bronchial muscles and reduces inflammation, while Erdosteine breaks down thick mucus, making it easier to remove from the lungs.\n\n3. Can Acebrophylline and Erdosteine Tablets treat chronic cough?\nYes. These tablets help relieve chronic productive cough by reducing mucus viscosity and improving airway clearance when prescribed by a healthcare professional.\n\n4. Are Acebrophylline and Erdosteine Tablets safe for long-term use?\nThey may be prescribed for long-term management of chronic respiratory diseases, but treatment duration should always be determined by a physician.\n\n5. Can these tablets be used for asthma?\nYes. Doctors may prescribe Acebrophylline and Erdosteine Tablets as part of asthma management when mucus accumulation and airway inflammation are significant.\n\n6. Do Acebrophylline and Erdosteine Tablets have side effects?\nMost side effects are mild and temporary, including nausea, headache, dizziness, stomach upset, and dry mouth. Serious reactions are uncommon but require immediate medical attention.\n\n7. Should Acebrophylline and Erdosteine Tablets be taken before or after food?\nThey are generally recommended after meals to reduce the risk of stomach irritation. Follow your doctor's advice regarding dosage and timing.\n\n8. Can smokers use Acebrophylline and Erdosteine Tablets?\nYes. Physicians often prescribe them to smokers suffering from chronic bronchitis, COPD, or mucus-related respiratory disorders.\n\n9. Are Acebrophylline and Erdosteine Tablets available for third-party manufacturing?\nYes. We offer third-party manufacturing, private labeling, customized packaging, and bulk pharmaceutical supply for domestic and international markets.\n\n10. Why buy Acebrophylline and Erdosteine Tablets from us?\nOur products are manufactured in WHO-GMP-certified facilities using premium-quality raw materials, strict quality control processes, competitive pricing, and reliable global distribution, making us a trusted pharmaceutical manufacturing partner.\n\nThis version is optimized for buyer intent, includes keyword-rich headings and FAQs designed for Google Search and voice search, and naturally targets the primary keyword “Acebrophylline and Erdosteine Tablets” throughout the content without excessive keyword stuffing.", "price": 360.0, "discountamount": 108.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2487, "imageuri": "https://productimages.withfloats.com/actual/6a685f3db435445dbdc3d469.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a685f3db435445dbdc3d469.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-28T07:50:18.551Z", "updatedon": "2026-07-28T07:50:18.551Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/acebrophylline-and-erdosteine-tablets/2487", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "STERIPHYLLIN ERDO", "category": "ASTHMA RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69cbc41faf13b43636b170d0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Everolimus Tablets 0.5 mg", "description": "EVERENOLIMUS 0.5 is a prescription medication containing Everolimus 0.5 mg tablets, a potent mTOR (mammalian target of rapamycin) inhibitor used in advanced medical treatments. This medicine works by regulating cell growth, division, and immune system activity, making it effective in both oncology and transplant care.\nEverolimus has become a crucial therapeutic option for patients requiring targeted cancer therapy or immunosuppression after organ transplantation. Its dual functionality—controlling abnormal cell proliferation and preventing organ rejection—makes it a preferred choice among healthcare providers.\nIn India, EVERENOLIMUS 0.5 is increasingly prescribed for specific cancers, post-transplant care, and rare disorders like tuberous sclerosis complex. Its oral tablet form allows convenient administration while maintaining effective systemic action.\n\nUses of EVERENOLIMUS 0.5\n\nEVERENOLIMUS 0.5 is indicated for a range of serious medical conditions:\n1. Organ Transplantation\nHelps prevent rejection of kidney and liver transplants\nMaintains graft survival by suppressing the immune response\n2. Cancer Treatment\nHormone receptor-positive, HER2-negative advanced breast cancer\nAdvanced kidney cancer (renal cell carcinoma)\nNeuroendocrine tumors (pancreas, lungs, gastrointestinal tract)\n3. Tuberous Sclerosis Complex (TSC)\nManages non-cancerous tumors such as subependymal giant cell astrocytoma (SEGA)\nReduces tumor growth in vital organs\n4. Other Rare Conditions\nCertain types of cardiac or renal vascular growth disorders, under specialist supervision\nBenefits of EVERENOLIMUS 0.5\n1. Dual Therapeutic Action\nOffers immunosuppressive benefits for transplant patients\nProvides targeted anti-cancer activity to control abnormal cell growth\n2. Improved Transplant Outcomes\nReduces the risk of graft rejection\nEnsures long-term functionality of transplanted organs\n3. Targeted Cancer Therapy\nFocuses on specific cellular pathways\nMinimizes damage to healthy cells compared to conventional chemotherapy\n4. Slows Disease Progression\nEffective in advanced cancers and benign tumors\nControls disease symptoms and improves patient quality of life\n5. Convenient Oral Formulation\nEasy to take as a tablet without injections\nEnables consistent and controlled drug delivery\n6. Enhances Long-Term Management\nRegular use supports chronic disease control\nReduces hospitalization and complication rates\nDosage of EVERENOLIMUS 0.5\n\nThe exact dosage depends on the patient’s condition, weight, and response to therapy. It must be determined by a healthcare professional.\n\nGeneral Guidelines:\nTypically taken once daily\nSwallow the tablet whole with water\nCan be taken with or without food, but maintain consistency\nMonitoring Requirements:\nRegular blood tests to check kidney and liver function\nMonitoring drug levels ensures effectiveness and safety\nMissed Dose:\nTake the missed dose as soon as possible\nIf it is near the next scheduled dose, skip the missed dose\nDo not double the dose\n\nSide Effects of EVERENOLIMUS 0.5\n\nEVERENOLIMUS 0.5 may cause side effects, which can range from mild to serious.\nCommon Side Effects:\nFatigue and weakness\nNausea or vomiting\nMouth ulcers\nDiarrhea\nLess Common Side Effects:\nEdema (swelling in hands or feet)\nIncreased blood sugar and cholesterol levels\nSkin rash\nSerious Side Effects:\nIncreased risk of infections due to suppressed immunity\nLung inflammation (non-infectious pneumonitis)\nImpaired kidney or liver function\nDelayed wound healing\nWhen to Seek Medical Attention:\nPersistent fever or signs of infection\nShortness of breath or chest pain\nSevere weakness, dizziness, or swelling\nUnusual bleeding or bruising\nPrecautions and Warning\n1. Infection Risk\nSuppressed immunity increases susceptibility to infections\nAvoid exposure to people with contagious diseases\n2. Liver and Kidney Function\nRegular tests are necessary to monitor organ health\n3. Vaccinations\nAvoid live vaccines during treatment\nConsult your doctor before any vaccination\n4. Drug Interactions\nInform your doctor about all medications, including antibiotics, antifungals, and supplements\n5. Pregnancy and Contraception\nNot recommended during pregnancy\nEffective contraception is advised during and after treatment\n6. Surgery and Wound Healing\nInform your doctor before undergoing surgery\nWound healing may be delayed due to Everolimus effects\n7. Sun Protection\nIncreased sensitivity to sunlight\nUse sunscreen and protective clothing\n\nConclusion\n\nEVERENOLIMUS 0.5 (Everolimus Tablets 0.5 mg) is a highly effective oral medication that offers dual benefits for cancer patients and organ transplant recipients. Its targeted mechanism ensures precise therapeutic action while minimizing unnecessary side effects.\nBy preventing organ rejection, controlling tumor growth, and improving long-term outcomes, EVERENOLIMUS 0.5 has become a trusted choice in modern clinical practice. Patients in India seeking reliable, medically supervised care for complex conditions can benefit greatly from this advanced therapy.\nStrict adherence to dosage, regular monitoring, and medical supervision are essential for safe and effective use. Combined with lifestyle and dietary guidance, EVERENOLIMUS 0.5 supports improved quality of life and enhanced clinical outcomes.", "price": 643.0, "discountamount": 193.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2359, "imageuri": "https://productimages.withfloats.com/actual/69cbc421595f848aedb0807c.png", "tileimageuri": "https://productimages.withfloats.com/tile/69cbc421595f848aedb0807c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-31T12:54:55.448Z", "updatedon": "2026-04-14T12:54:29.458Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//everolimus-tablets-0-5-mg/2359", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EVERENOLIMUS 0.5", "category": "Oncology", "tags": [ "everolimus tablets 0.5 mg uses", "everolimus 0.5 mg dosage and benefits", "everolimus 0.5 mg side effects and precautions", "everolimus 0.5 mg mechanism of action", "everolimus 0.5 mg tablet guide", "everolimus 0.5 mg price in India", "everolimus tablets bulk supplier", "best everolimus tablets 0.5 mg price and uses India", "buy everolimus 0.5 mg tablets online at best price", "everolimus tablets for organ transplant patients India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69abfef2c81325b02fe38a1e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ambroxol + guaifenesin + terbutaline", "description": "RAPIDKOF XT is a highly effective combination medication that contains Ambroxol, Guaifenesin, and Terbutaline, specifically formulated to provide relief from respiratory tract disorders such as cough, congestion, and bronchial asthma. This triple-action formulation is widely used for managing productive cough, thick mucus accumulation, and airway constriction, offering a comprehensive approach to respiratory care.\n\nThe synergistic combination of a mucolytic, an expectorant, and a bronchodilator in RAPIDKOF XT ensures effective clearing of mucus, relaxation of bronchial muscles, and easier breathing. This makes it an ideal choice for patients suffering from chronic bronchitis, asthma exacerbations, and respiratory infections with productive cough. By targeting multiple pathways involved in respiratory distress, RAPIDKOF XT provides faster symptomatic relief and supports better lung function.\n\nIt is essential to use RAPIDKOF XT under medical supervision, as proper dosage and duration are crucial for safe and effective treatment.\n\nComposition\n\nEach RAPIDKOF XT tablet or syrup (depending on the formulation) contains:\n\nAmbroxol – a mucolytic agent that thins and loosens mucus in the airways.\n\nGuaifenesin—an expectorant that promotes the removal of mucus from the respiratory tract.\n\nTerbutaline is a bronchodilator that relaxes the smooth muscles of the airways, improving airflow.\n\nThis combination provides multi-level relief by addressing mucus accumulation, airway constriction, and cough simultaneously.\n\nHow RAPIDKOF XT Works\n\nThe effectiveness of RAPIDKOF XT lies in its triple-action mechanism:\n\nAmbroxol\n\nAmbroxol works as a mucolytic agent by breaking down the structure of thick, sticky mucus in the respiratory tract. This action makes it easier for patients to cough up phlegm, reducing airway obstruction and improving oxygen exchange. Ambroxol also enhances the protective function of respiratory mucosa by stimulating surfactant production.\n\nGuaifenesin\n\nGuaifenesin is an expectorant that promotes the expulsion of mucus from the lungs and bronchi. It increases the volume of secretions while reducing their viscosity, which helps in clearing the airways and alleviating productive cough.\n\nTerbutaline\n\nTerbutaline is a selective beta-2 adrenergic agonist, a type of bronchodilator. It relaxes the smooth muscles in the airways, leading to widening of the bronchial passages. This action reduces wheezing, shortness of breath, and chest tightness associated with asthma and other obstructive airway conditions.\n\nUses of RAPIDKOF XT\n\nRAPIDKOF XT is indicated for various respiratory conditions where mucus accumulation, cough, and airway constriction coexist.\n\n1. Productive Cough\n\nIt helps patients with thick and sticky phlegm by thinning mucus, making it easier to expel through coughing.\n\n2. Chronic and Acute Bronchitis\n\nRAPIDKOF XT provides relief from inflammation, mucus buildup, and bronchial spasm, improving breathing and reducing discomfort.\n\n3. Asthma and Bronchospasm\n\nTerbutaline in the formulation helps relax constricted airways, making it suitable for patients with asthmatic bronchitis or mild to moderate asthma exacerbations.\n\n4. Respiratory Tract Infections\n\nThe combination aids recovery from viral or bacterial respiratory infections by facilitating mucus clearance and alleviating associated cough and congestion.\n\n5. Other Obstructive Pulmonary Conditions\n\nRAPIDKOF XT may be prescribed in conditions such as chronic obstructive pulmonary disease (COPD), where airway obstruction and mucus accumulation are major issues.\n\nKey Benefits of RAPIDKOF XT\n\nRAPIDKOF XT offers multiple therapeutic benefits due to the synergistic action of its components:\n\nEffective Mucus Clearance\n\nAmbroxol and guaifenesin work together to loosen and expel mucus, improving airway patency and reducing cough severity.\n\nRelief from Bronchospasm\n\nTerbutaline relaxes airway muscles, helping patients breathe more easily and reducing wheezing, tightness, and shortness of breath.\n\nSymptomatic Relief from Cough\n\nThe combination reduces both productive and irritating cough, enhancing comfort and improving sleep quality.\n\nSupport for Respiratory Recovery\n\nBy facilitating mucus clearance and improving airflow, RAPIDKOF XT supports faster recovery from infections and inflammatory airway conditions.\n\nImproved Oxygenation and Energy\n\nBetter airway clearance and bronchodilation allow improved oxygen intake, which enhances overall energy levels and reduces fatigue associated with respiratory distress.\n\nSuitable for Both Acute and Chronic Conditions\n\nRAPIDKOF XT can be used in both short-term respiratory infections and long-term management of chronic bronchial conditions, depending on a doctor’s guidance.\n\nRecommended Dosage and Administration\n\nThe dosage of RAPIDKOF XT should always follow medical prescription, and the form of administration (tablet or syrup) may vary depending on the patient’s age and severity of symptoms.\n\nAdults: Typically 1 tablet or a measured dose of syrup 2–3 times daily.\n\nChildren: Dosage should be adjusted according to age and weight as advised by a doctor.\n\nTake with water after meals to reduce the risk of stomach upset.\n\nContinue the full course as prescribed, even if symptoms improve.\n\nPossible Side Effects of RAPIDKOF XT\n\nMost patients tolerate RAPIDKOF XT well. However, some individuals may experience mild side effects, and serious reactions, though rare, are possible.\n\nCommon Side Effects\n\nMild nausea or stomach upset\n\nHeadache or dizziness\n\nTremors (from terbutaline)\n\nPalpitations or increased heart rate in sensitive individuals\n\nLess Common Side Effects\n\nDry mouth or throat irritation\n\nMild rash or skin itching\n\nTemporary restlessness or insomnia\n\nRare but Serious Side Effects\n\nSevere allergic reactions (swelling, difficulty breathing)\n\nSevere tachycardia or irregular heartbeat\n\nLow potassium levels (with prolonged terbutaline use)\n\nSevere gastrointestinal discomfort\n\nPatients experiencing serious side effects should seek immediate medical attention.\n\nPrecautions and Safety Information\n\nConsult your doctor if you have heart disease, high blood pressure, diabetes, or thyroid disorders before taking RAPIDKOF XT.\n\nAvoid using other stimulants or bronchodilators without medical guidance.\n\nPregnant or breastfeeding women should use the medication only under strict medical supervision.\n\nInform your doctor about all medications being taken to avoid drug interactions.\n\nUse with caution in elderly patients due to increased sensitivity to terbutaline.\n\nStorage Instructions\n\nStore in a cool, dry place below 30°C.\n\nKeep away from direct sunlight, heat, and moisture.\n\nKeep out of reach of children.\n\nDo not use after the expiration date on the packaging.\n\nConclusion\nRAPIDKOF XT is a triple-action respiratory medication that combines Ambroxol, Guaifenesin, and Terbutaline to provide comprehensive relief from cough, mucus accumulation, and bronchial constriction. Its unique formulation ensures faster symptomatic relief, improved airway clearance, and enhanced respiratory function.", "price": 120.0, "discountamount": 36.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2320, "imageuri": "https://productimages.withfloats.com/actual/69abfef4e43af51a7012aa5e.png", "tileimageuri": "https://productimages.withfloats.com/tile/69abfef4e43af51a7012aa5e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-07T10:33:22.778Z", "updatedon": "2026-03-14T06:50:49.737Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//ambroxol-guaifenesin-terbutaline/2320", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RAPIDKOF XT", "category": "GENERAL RANGE", "tags": [ "Ambroxol guaifenesin terbutaline cough syrup", "Triple action cough relief medicine", "Cough syrup for thick mucus and wheezing", "Asthma and bronchitis cough medicine", "Buy Ambroxol Guaifenesin Terbutaline syrup online", "Best price cough and mucus clearing syrup", "Shop Ambroxol Terbutaline combination online" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69942f823b20a66d9dcf9458", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "fdc of indacaterol maleate and glycopyrronium bromide inhalation powder", "description": "GLYCOPRESS INDUS™ is a modern dual bronchodilator therapy formulated with Indacaterol Maleate and Glycopyrronium Bromide, designed for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD). This advanced inhalation formulation combines two complementary mechanisms of action to deliver sustained airway relaxation, improved lung function, and enhanced breathing comfort.\n\nCOPD is a progressive respiratory condition characterized by airflow limitation, chronic inflammation, and episodes of breathlessness. Effective management requires consistent bronchodilation to keep the airways open and reduce daily symptoms. GLYCOPRESS INDUS™ addresses this need through a once-daily maintenance approach that targets airway narrowing through dual pharmacological pathways.\n\nManufactured under strict quality standards, GLYCOPRESS INDUS™ ensures reliable dosing, stability, and optimal pulmonary delivery when used with the recommended inhalation device. It is intended for regular use and not for the treatment of sudden breathing emergencies.\n\nComposition and Mechanism of Action\n\nGLYCOPRESS INDUS™ combines two long-acting bronchodilators:\n\n1. Indacaterol Maleate (Long-Acting Beta2-Agonist – LABA)\n\nIndacaterol stimulates beta2-adrenergic receptors located in the smooth muscles of the airways. Activation of these receptors causes the muscles to relax, resulting in bronchodilation. This effect:\n\nReduces airway resistance\n\nImproves airflow\n\nDecreases breathlessness\n\nSupports 24-hour bronchodilation\n\nIndacaterol is known for its rapid onset and prolonged duration of action, making it effective for once-daily therapy.\n\n2. Glycopyrronium Bromide (Long-Acting Muscarinic Antagonist – LAMA)\n\nGlycopyrronium blocks muscarinic receptors in the bronchial smooth muscles. These receptors normally respond to acetylcholine, which causes airway constriction. By inhibiting this response, glycopyrronium:\n\nPrevents bronchospasm\n\nReduces airway tightening\n\nPromotes sustained airway relaxation\n\nDual-Action Advantage\n\nThe combination of LABA and LAMA in GLYCOPRESS INDUS™ provides enhanced bronchodilation compared to either agent alone. While indacaterol actively relaxes airway muscles, glycopyrronium prevents them from tightening. This complementary action ensures comprehensive and sustained airway management.\n\nIndications and Uses\n\nGLYCOPRESS INDUS™ is indicated for:\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD)\n\nChronic bronchitis management\n\nEmphysema management\n\nLong-term airflow limitation therapy\n\nIt is important to understand that GLYCOPRESS INDUS™:\n\nIs not a rescue inhaler\n\nShould not be used for sudden acute bronchospasm\n\nIs not intended for primary asthma treatment unless prescribed by a physician\n\nPatients should always keep a short-acting bronchodilator available for emergency relief.\n\nKey Benefits of GLYCOPRESS INDUS™\n1. Once-Daily Dosing Convenience\n\nGLYCOPRESS INDUS™ is formulated for once-daily administration, improving adherence and simplifying treatment routines.\n\n2. Dual Bronchodilation for Superior Airway Control\n\nThe LABA + LAMA combination provides broader and more effective airway relaxation compared to single-agent therapy.\n\n3. Rapid Onset with Sustained Effect\n\nIndacaterol provides quick bronchodilation, while glycopyrronium maintains airway openness for up to 24 hours.\n\n4. Improved Lung Function\n\nRegular use can enhance lung performance parameters, such as improved airflow measurements and reduced air trapping.\n\n5. Reduced Breathlessness\n\nPatients may experience decreased shortness of breath during physical activities, leading to greater independence.\n\n6. Lower Frequency of COPD Exacerbations\n\nConsistent airway maintenance can help reduce the likelihood of flare-ups and hospital visits.\n\n7. Enhanced Quality of Life\n\nBetter breathing control contributes to improved sleep, increased exercise tolerance, and overall well-being.\n\nDosage and Administration\n\nGLYCOPRESS INDUS™ should be used exactly as prescribed by a healthcare professional.\n\nGeneral Administration Guidelines:\n\nUse once daily at the same time each day.\n\nInhale using the provided inhalation device.\n\nDo not swallow capsules (if capsule-based system).\n\nDo not exceed the recommended dose.\n\nFollow inhaler technique instructions carefully.\n\nProper inhalation technique is essential for effective drug delivery. Healthcare providers should demonstrate correct usage during initial prescription.\n\nPossible Side Effects\n\nWhile GLYCOPRESS INDUS™ is generally well tolerated, some individuals may experience side effects.\n\nCommon Side Effects\n\nDry mouth\n\nCough\n\nThroat irritation\n\nHeadache\n\nNasal congestion\n\nMild tremor\n\nDizziness\n\nThese symptoms are often mild and may diminish with continued use.\n\nCardiovascular Effects\n\nDue to the beta2-agonist component (indacaterol), some patients may experience:\n\nIncreased heart rate\n\nPalpitations\n\nMild fluctuations in blood pressure\n\nPatients with pre-existing heart conditions should consult their physician before starting therapy.\n\nAnticholinergic Effects (from Glycopyrronium)\n\nDifficulty urinating\n\nBlurred vision\n\nWorsening of narrow-angle glaucoma\n\nIndividuals with urinary retention or glaucoma should use caution.\n\nRare but Serious Reactions\n\nParadoxical bronchospasm (worsening breathing immediately after inhalation)\n\nSevere allergic reactions\n\nSignificant cardiac rhythm disturbances\n\nImmediate medical attention should be sought if severe reactions occur.\n\nPrecautions and Warnings\n\nBefore starting GLYCOPRESS INDUS™, inform your healthcare provider if you have:\n\nCardiovascular disease\n\nArrhythmias\n\nHypertension\n\nHyperthyroidism\n\nDiabetes\n\nSeizure disorders\n\nGlaucoma\n\nProstate enlargement\n\nKidney impairment\n\nDrug Interactions\n\nCaution is required when using:\n\nOther long-acting beta2-agonists\n\nOther anticholinergic medications\n\nBeta-blockers\n\nDiuretics\n\nCertain antidepressants (e.g., MAO inhibitors)\n\nAlways provide a complete list of medications and supplements to your healthcare provider.\n\nWho Should Use GLYCOPRESS INDUS™?\n\nGLYCOPRESS INDUS™ is ideal for:\n\nAdults with moderate to severe COPD\n\nPatients not adequately controlled on single bronchodilator therapy\n\nIndividuals seeking a once-daily maintenance inhaler\n\nPatients requiring dual bronchodilation for improved symptom control\n\nIt is not typically recommended for pediatric patients unless specifically directed by a healthcare professional.\n\nIntegrating GLYCOPRESS INDUS™ into COPD Management\n\nFor optimal results, GLYCOPRESS INDUS™ should be part of a comprehensive COPD management plan that includes:\n\nSmoking cessation\n\nPulmonary rehabilitation programs\n\nRegular physical activity\n\nBalanced nutrition\n\nScheduled medical follow-ups\n\nAdherence to therapy and routine monitoring significantly improve long-term outcomes.\n\nStorage Instructions\n\nStore at room temperature\n\nProtect from moisture and direct sunlight\n\nKeep in original packaging until use\n\nKeep out of reach of children\nConclusion\nGLYCOPRESS INDUS™ (Indacaterol Maleate + Glycopyrronium Bromide) is a powerful dual bronchodilator designed to provide sustained airway control in individuals living with chronic obstructive pulmonary disease. By combining a long-acting beta2-agonist and a long-acting muscarinic antagonist, it offers comprehensive bronchodilation through two complementary pathways.", "price": 703.0, "discountamount": 211.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2308, "imageuri": "https://productimages.withfloats.com/actual/69942f8410196f5f212c916f.png", "tileimageuri": "https://productimages.withfloats.com/tile/69942f8410196f5f212c916f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-17T09:06:10.4Z", "updatedon": "2026-04-08T08:59:59.008Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//fdc-of-indacaterol-maleate-and-glycopyrronium-bromide-inhalation-powder/2308", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLYCOPRESS INDUS", "category": "ASTHMARANGE", "tags": [ "indacaterol maleate", "fdc of indacaterol maleate uses", "fdc of indacaterol maleate uses in hindi", "fdc of indacaterol maleate and glycopyrronium bromide inhalation powder", "indacaterol maleate and glycopyrronium bromide", "indacaterol maleate glycopyrronium bromide price", "fdc of indacaterol maleate" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69747bdec522c2b149071d3b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sodium Chloride Inhalation Solution USP 3% w/v", "description": "SODICHLOR 3% is a sterile, preservative-free hypertonic saline inhalation solution specifically formulated to help manage respiratory conditions characterized by thick, tenacious mucus secretions. This pharmaceutical-grade formulation contains 3% sodium chloride in purified water, offering a concentration three times higher than normal saline, designed to work through osmotic principles to improve airway clearance and respiratory function.\nAs a trusted therapeutic agent in respiratory care, SODICHLOR 3% represents a non-antibiotic approach to managing chronic respiratory conditions, making it an invaluable tool for patients suffering from cystic fibrosis, chronic obstructive pulmonary disease (COPD), bronchiectasis, and other conditions where mucus clearance is compromised. The solution is administered via nebulization, allowing the medication to reach deep into the bronchial passages where it can exert its therapeutic effects most effectively.\nHow SODICHLOR 3% Works\nThe mechanism of action behind SODICHLOR 3% is elegantly simple yet highly effective. When nebulized and inhaled, the hypertonic saline solution creates an osmotic gradient in the airways. This means that the higher salt concentration in the solution draws water from the surrounding tissues into the airway surface liquid layer. This influx of water hydrates the mucus, making it less viscous and sticky, which significantly improves the ability to cough up and clear secretions from the lungs.\nAdditionally, SODICHLOR 3% helps restore the normal salt and water balance on airway surfaces, which is particularly important in conditions like cystic fibrosis where this balance is naturally disrupted. The solution also stimulates ciliary beat frequency, enhancing the natural cleaning mechanism of the respiratory tract. By improving mucociliary clearance, SODICHLOR 3% helps reduce the bacterial burden in the airways, potentially decreasing the frequency of respiratory infections and exacerbations.\nPrimary Uses and Applications\nSODICHLOR 3% is prescribed for various respiratory conditions where enhanced mucus clearance is clinically beneficial:\nCystic Fibrosis Management: Perhaps the most well-established use, SODICHLOR 3% has become a cornerstone therapy for patients with cystic fibrosis. Regular use helps thin the abnormally thick mucus characteristic of this genetic condition, improving lung function and quality of life while reducing the risk of pulmonary exacerbations.\nChronic Obstructive Pulmonary Disease: For COPD patients who struggle with excessive mucus production and poor clearance, SODICHLOR 3% provides relief by facilitating easier expectoration and improving breathing comfort.\nBronchiectasis: This condition, characterized by permanently damaged and widened airways that trap mucus, benefits significantly from hypertonic saline therapy. SODICHLOR 3% helps clear the pooled secretions that contribute to recurrent infections.\nPost-Operative Respiratory Care: Following certain surgical procedures, particularly thoracic surgeries, SODICHLOR 3% may be used to prevent mucus plugging and atelectasis by maintaining adequate airway hydration.\nSputum Induction: In diagnostic settings, SODICHLOR 3% can be used to induce sputum production for laboratory testing when patients cannot spontaneously produce adequate samples.\nKey Benefits of SODICHLOR 3%\nThe therapeutic advantages of SODICHLOR 3% extend across multiple dimensions of respiratory health:\nEnhanced Mucus Clearance: The primary benefit is the dramatic improvement in the ability to clear thick, sticky mucus from the airways. Patients often report easier breathing and more productive coughing within minutes of treatment.\nImproved Lung Function: Clinical studies have demonstrated that regular use of hypertonic saline solutions like SODICHLOR 3% can lead to measurable improvements in pulmonary function tests, including forced expiratory volume (FEV1) and forced vital capacity (FVC).\nReduced Infection Frequency: By promoting better mucus clearance and reducing bacterial colonization in the airways, SODICHLOR 3% may help decrease the frequency of respiratory infections and disease exacerbations, leading to fewer hospitalizations.\nNon-Antibiotic Therapy: In an era of increasing antibiotic resistance, SODICHLOR 3% offers a mechanical rather than chemical approach to managing respiratory symptoms, making it a valuable addition to any treatment regimen without contributing to resistance patterns.\nCost-Effective Treatment: Compared to many specialized respiratory medications, SODICHLOR 3% represents a relatively affordable therapeutic option that can be used long-term without prohibitive expense.\nQuality of Life Enhancement: Patients using SODICHLOR 3% regularly often report significant improvements in their daily activities, exercise tolerance, and overall sense of well-being due to easier breathing and reduced respiratory distress.\nCompatibility with Other Treatments: SODICHLOR 3% can be safely used alongside other respiratory medications, including bronchodilators, corticosteroids, and antibiotics, as part of a comprehensive treatment plan.\nPotential Side Effects and Considerations\nWhile SODICHLOR 3% is generally well-tolerated, patients should be aware of potential side effects:\nCommon Side Effects: The most frequently reported adverse effects include throat irritation, coughing (especially initially), unpleasant taste, and mild wheezing or chest tightness. These effects are typically transient and often diminish with continued use as the body adapts to the therapy.\nBronchospasm: Some patients, particularly those with hyperreactive airways or asthma, may experience bronchospasm (sudden narrowing of the airways) during or after treatment. This is why healthcare providers often recommend using a bronchodilator before SODICHLOR 3% administration.\nTemporary Oxygen Desaturation: In some cases, especially in patients with severe lung disease, temporary decreases in blood oxygen levels may occur immediately after treatment, though levels typically return to baseline within 30 minutes.\nNasal Congestion and Rhinorrhea: Some patients may experience nasal stuffiness or runny nose following inhalation therapy.\nLess Common Effects: Headache, nausea, dizziness, or voice changes may occasionally occur but are generally mild and self-limiting.\nPatients with certain conditions such as uncontrolled hypertension, severe electrolyte imbalances, or recent hemoptysis should use SODICHLOR 3% only under close medical supervision. As with any medical treatment, it's essential to discuss your complete medical history with your healthcare provider before beginning therapy.\nConclusion\nSODICHLOR 3% represents a scientifically sound, clinically proven approach to managing respiratory conditions complicated by thick mucus secretions. Its mechanism of action—leveraging osmotic principles to hydrate and mobilize airway secretions—addresses a fundamental problem faced by millions of patients with chronic respiratory diseases. The substantial body of evidence supporting its efficacy, combined with its favorable safety profile and cost-effectiveness, makes SODICHLOR 3% an indispensable component of modern respiratory care.", "price": 540.0, "discountamount": 162.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2283, "imageuri": "https://productimages.withfloats.com/actual/69747be5cf228670cde34180.png", "tileimageuri": "https://productimages.withfloats.com/tile/69747be5cf228670cde34180.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-24T07:59:26.118Z", "updatedon": "2026-03-14T07:09:16.685Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sodium-chloride-inhalation-solution-usp-3-w-v/2283", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SODICHLOR 3%", "category": "ASTHMARANGE", "tags": [ "sodium chloride inhalation solution usp 3 percent", "sodium chloride 3% nebulizer solution", "sodium chloride 3% respiratory solution", "sodium chloride inhalation solution usp 3% price", "buy sodium chloride 3% inhalation solution", "sodium chloride 3% nebulizer solution manufacturer", "sodium chloride inhalation solution usp 3% benefits", "sodium chloride inhalation solution usp 3% benefits", "sodium chloride inhalation solution usp 3% dosage", "sodium chloride inhalation solution usp 3% side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694d181a5837f90c86a7e9f9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Frusemide IP 40mg ", "description": "FRUSIP 40 is a pharmaceutical formulation containing Frusemide IP 40mg as its active ingredient, presented in tablet form for oral administration. This medication belongs to the class of loop diuretics, which are among the most potent diuretic agents available in modern medicine. FRUSIP 40 is specifically designed to help manage conditions associated with fluid retention and elevated blood pressure, offering patients a reliable therapeutic solution for maintaining optimal fluid balance in the body.\nThe formulation adheres to Indian Pharmacopoeia (IP) standards, ensuring consistent quality, purity, and efficacy. Each tablet is precisely manufactured to deliver the exact dosage required for effective treatment while maintaining the highest safety standards in pharmaceutical production.\nUnderstanding Furosemide and Its Mechanism\nFrusemide, also known as furosemide in some regions, is a powerful loop diuretic that works primarily in the kidneys. The medication exerts its therapeutic effect by inhibiting the reabsorption of sodium and chloride in the ascending loop of Henle, a specific segment of the kidney's nephron. This action prevents the body from retaining excess salt and water, leading to increased urine production and the subsequent elimination of accumulated fluids.\nThe “loop” designation comes from the specific site of action within the kidney's loop of Henle, making frusemide significantly more potent than thiazide diuretics that work in different parts of the kidney. This enhanced potency makes FRUSIP 40 particularly valuable in managing conditions requiring substantial fluid removal.\nPrimary Uses and Indications\nFRUSIP 40 is prescribed for various medical conditions where fluid accumulation poses health risks or causes discomfort:\nEdema Management: The medication is highly effective in treating edema (swelling) associated with congestive heart failure, where the heart's reduced pumping efficiency leads to fluid buildup in the lungs, legs, and other tissues. It helps alleviate breathing difficulties and reduces the strain on the cardiovascular system.\nLiver Disease: Patients with cirrhosis or other liver conditions often develop ascites, an accumulation of fluid in the abdominal cavity. FRUSIP 40 helps manage this uncomfortable and potentially dangerous condition by promoting fluid elimination.\nKidney Disorders: In cases of nephrotic syndrome and other renal conditions causing fluid retention, this medication assists in maintaining proper fluid balance, though it must be used judiciously under medical supervision in patients with compromised kidney function.\nHypertension Control: FRUSIP 40 serves as an effective antihypertensive agent, helping to lower blood pressure by reducing blood volume through increased fluid excretion. This is particularly beneficial for patients whose hypertension is resistant to other treatments.\nPulmonary Edema: In acute situations where fluid accumulates in the lungs, this medication can provide rapid relief, making it a valuable tool in emergency medical settings.\nKey Benefits and Therapeutic Advantages\nThe advantages of FRUSIP 40 extend beyond its primary diuretic function, offering patients multiple therapeutic benefits:\nRapid Onset of Action: One of the most significant advantages is the quick response time. Patients typically experience diuretic effects within 30 to 60 minutes of oral administration, with peak effects occurring within one to two hours. This rapid action is particularly valuable in acute situations requiring prompt fluid removal.\nPotent Efficacy: As a loop diuretic, FRUSIP 40 demonstrates superior diuretic potency compared to thiazide diuretics, making it the preferred choice for patients with severe fluid retention or those who haven't responded adequately to milder diuretics.\nCardiovascular Protection: By reducing fluid overload, the medication decreases the workload on the heart, helping to prevent complications in patients with heart failure. This protective effect can significantly improve quality of life and potentially reduce hospitalizations.\nSymptom Relief: Patients often experience notable improvement in symptoms such as shortness of breath, swelling in the extremities, and abdominal distension. This symptomatic relief contributes to enhanced mobility and daily functioning.\nFlexible Dosing: The 40mg strength allows healthcare providers to adjust treatment according to individual patient needs, either maintaining this dose or modifying it based on therapeutic response and tolerance.\nElectrolyte Management: When used under proper medical supervision with appropriate monitoring, the medication allows for controlled fluid management while maintaining awareness of electrolyte balance.\nPotential Side Effects and Considerations\nWhile FRUSIP 40 is generally well-tolerated, patients should be aware of potential side effects:\nCommon Side Effects: These include increased urination frequency (which is expected), dizziness or lightheadedness upon standing (due to reduced blood volume), muscle cramps, and mild headaches. These effects often diminish as the body adjusts to the medication.\nElectrolyte Imbalances: The medication can cause depletion of important electrolytes, including potassium, sodium, magnesium, and calcium. Symptoms may include weakness, irregular heartbeat, confusion, or severe muscle cramps. Regular monitoring through blood tests is essential.\nDehydration Risk: Excessive fluid loss can lead to dehydration, characterized by extreme thirst, dry mouth, decreased urine output, and confusion. Patients must maintain adequate fluid intake as directed by their healthcare provider.\nMetabolic Effects: Some patients may experience increased blood sugar levels, elevated uric acid (potentially triggering gout attacks), or changes in cholesterol levels.\nHearing Changes: Rarely, particularly at higher doses, patients may experience ringing in the ears (tinnitus) or temporary hearing impairment.\nPhotosensitivity: Increased sensitivity to sunlight may occur, requiring appropriate sun protection measures.\nDrug Interactions: FRUSIP 40 can interact with numerous medications, including certain antibiotics, other blood pressure medications, NSAIDs, and lithium, necessitating comprehensive medication review by healthcare providers.\nImportant Safety Information\nPatients taking FRUSIP 40 should inform their healthcare provider about any existing medical conditions, particularly kidney disease, liver disease, diabetes, gout, or lupus. Pregnant and breastfeeding women require special consideration, as the medication crosses the placenta and appears in breast milk.\nRegular monitoring of kidney function, electrolyte levels, and blood pressure is essential for safe and effective therapy. Patients should maintain consistent communication with their healthcare team and report any unusual symptoms promptly.\nConclusion\nFRUSIP 40 (Frusemide IP 40mg Tablets) represents a cornerstone therapy in the management of conditions involving fluid retention and hypertension. Its potent diuretic action, rapid onset, and proven efficacy make it an invaluable tool in cardiovascular and renal medicine. The medication offers significant benefits in symptom relief, cardiovascular protection, and overall quality of life improvement for patients struggling with edema and related conditions.\nHowever, the power of this medication demands respect and proper medical supervision. The potential for electrolyte imbalances and other side effects necessitates regular monitoring and open communication between patients and healthcare providers. When used appropriately under medical guidance, with proper monitoring and patient education, FRUSIP 40 can dramatically improve patient outcomes and help individuals regain control over conditions that significantly impact their daily lives.\nPatients prescribed FRUSIP 40 should view this medication as part of a comprehensive treatment plan that may include dietary modifications, lifestyle changes, and other medications. Success with this therapy depends on adherence to prescribed dosing, regular follow-up appointments, and proactive management of potential side effects. With proper use, FRUSIP 40 continues to serve as a trusted and effective therapeutic option for millions of patients worldwide requiring diuretic therapy.", "price": 14.0, "discountamount": 5.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2255, "imageuri": "https://productimages.withfloats.com/actual/694d1821ad363997d8b04dfb.png", "tileimageuri": "https://productimages.withfloats.com/tile/694d1821ad363997d8b04dfb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-25T10:55:22.405Z", "updatedon": "2026-04-18T09:37:29.473Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//frusemide-ip-40mg-/2255", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "FRUSIP 40", "category": "UROLOGYRANGE", "tags": [ "FRUSIP 40", "It helps alleviate breathing difficulties and reduces the strain on the cardiovascular system.", "fluid buildup in the lungs, legs, and other tissues.", "Metabolic Effects.", "frusemide 40mg", "tab frusemide 40mg", "frusemide 40mg use", "frusemide 40mg hindi", "frusemide 40mg tablet", "frusemide 40mg uses", "frusemide 40mg price", "tab frusemide 40mg use" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6926f07d1a6e5ed700f07efd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Ambrisentan 5mg, Tadalafil 20mg", "description": "Ambrisentan + Tadalafil (5 mg + 20mg) is a combination medication primarily used to treat pulmonary arterial hypertension (PAH), a condition characterized by high blood pressure in the arteries of the lungs. This combination works through a synergistic dual mechanism of action to improve pulmonary vascular health and reduce the strain on the heart.\n\nAmbrisentan acts as an endothelin receptor antagonist, selectively blocking endothelin type A receptors. Endothelin is a naturally occurring substance that causes blood vessels to constrict, increasing blood pressure. By blocking these receptors, ambrisentan helps to relax and widen the pulmonary arteries, reducing vascular resistance and improving blood flow. Tadalafil, on the other hand, is a phosphodiesterase type 5 (PDE5) inhibitor that increases cyclic guanosine monophosphate (cGMP) levels, leading to vasodilation and enhanced blood flow. Together, these two drugs complement each other by reducing vessel constriction and promoting dilation, effectively lowering pulmonary arterial pressure and helping the right side of the heart pump more efficiently.\n\nThe key benefits of the Ambrisentan + Tadalafil combination include improved exercise capacity, better heart function, and reduced symptoms of PAH such as shortness of breath and fatigue. Clinical studies have demonstrated that this combination significantly improves hemodynamics—the dynamics of blood flow—by reducing pulmonary vascular resistance and improving right ventricular (RV) function and structure. It also helps enhance patients' quality of life by increasing their ability to perform physical activities.\n\nWhile the combination is generally well tolerated, some side effects may occur. Common side effects include headache, nasal congestion, flushing, and swelling of the ankles or legs, which are typical of vasodilator therapies. Some patients may experience gastrointestinal symptoms such as nausea or indigestion. Less commonly, serious side effects such as liver enzyme elevation, hypotension (low blood pressure), or allergic reactions may occur. Patients should consult healthcare professionals before using this combination, especially those with low blood pressure, liver issues, or those taking nitrates due to potential interactions.\n\nIn conclusion, Ambrisentan + Tadalafil (5mg + 20mg) provides an effective treatment option for patients with pulmonary arterial hypertension by combining two complementary mechanisms to relax and dilate pulmonary arteries, decrease vascular resistance, and improve heart function and exercise tolerance. Patients are advised to use this medication under medical supervision to ensure safety and monitor for possible side effects. This combination therapy represents a significant advancement in managing PAH and improving patient outcomes.\nThis product is an important therapeutic option and should be integrated into a comprehensive PAH management plan that includes lifestyle modifications, regular monitoring, and adherence to prescribed treatment.", "price": 1800.0, "discountamount": 951.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2220, "imageuri": "https://productimages.withfloats.com/actual/6926f08fce3236cca23d19b7.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/6926f08fce3236cca23d19b7.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-26T12:20:13.462Z", "updatedon": "2026-03-14T08:20:11.529Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//ambrisentan-5mg-tadalafil-20mg/2220", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "AMBRISTAR 5 + DURA 20 ", "category": "cardiology", "tags": [ "Ambrisentan + Tadalafil (5 mg + 20mg)", "ambrisentan + tadalafil.", "increasing blood pressure.", "ambrisentan + tadalafil.", "ambrisentan + tadalafil combination.", "high blood pressure in the arteries of the lungs.", "ambrisentan tadalafil combination.", "ambrisentan tadalafil.", "tab ambrisentan tadalafil.", "ambrisentan tadalafil price.", "ambrisentan tadalafil uses in hindi.", "ambrisentan tadalafil fixed dose combination." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68fcbf512c3c0e60f0e9234a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "formoterol fluticasone inhaler", "description": "INH AIRFLOW MAX F250 combines two trusted respiratory agents — Formoterol (6 mcg) and Fluticasone (250 mcg) — in one convenient inhaler. This dual-therapy formulation is designed to deliver both rapid bronchodilation and long-term anti-inflammatory control, helping patients manage asthma and chronic obstructive pulmonary disease (COPD) more effectively.\nManufactured by Steris Healthcare Pvt. Ltd., INH AIRFLOW MAX F250 ensures reliable performance, quality assurance, and enhanced patient compliance.\nKey Indications\nINH AIRFLOW MAX F250 is indicated for:\nAsthma Maintenance Therapy: Provides long-term control of moderate to severe asthma.\nSymptom Relief: Reduces shortness of breath, wheezing, chest tightness, and airway inflammation.\nCOPD Management: Controls chronic respiratory symptoms and reduces the frequency and severity of COPD exacerbations.\nMechanism of Action\nINH AIRFLOW MAX F250 works through two complementary mechanisms:\n1. Formoterol (6 mcg) — Long-Acting Beta Agonist (LABA)\nAction: Relaxes airway smooth muscles for rapid and sustained bronchodilation.\nBenefit: Provides relief within minutes and lasts up to 12 hours.\n2. Fluticasone (250 mcg) — Corticosteroid\nAction: Reduces airway inflammation and prevents swelling of the bronchial walls.\nBenefit: Improves long-term respiratory control and reduces the risk of asthma attacks.\nTogether, these agents ensure both immediate symptom relief and prolonged protection against respiratory flare-ups.\nDosage and Administration\nRecommended Dose: As prescribed by a physician — usually one or two inhalations twice daily.\nRoute: Oral inhalation only.\nTiming: Use at the same time each day for best results.\nTechnique: Shake well before use and rinse mouth after each use to prevent throat irritation or infection.\n⚠️ Always follow your doctor’s instructions. Do not self-adjust or discontinue the medicine without consultation.\nKey Benefits of INH AIRFLOW MAX F250\n Provides dual-action relief — rapid bronchodilation + anti-inflammatory control.\n Ensures better breathing comfort and reduced daily symptoms.\n Prevents asthma and COPD exacerbations, improving long-term lung function.\n Convenient single-inhaler therapy improves adherence and treatment consistency.\n Suitable for chronic use under medical supervision.\nPossible Side Effects\nCommon Side Effects:\nThroat irritation or hoarseness\nMild headache\nTremor or shakiness\nNausea or cough\nSerious but Rare Side Effects:\nRespiratory infections (e.g., pneumonia)\nAllergic reactions (rash, swelling, or difficulty breathing)\nReduced bone density with long-term steroid use\nRinse your mouth after each inhalation to lower the risk of oral thrush or irritation.\nSafety and Precautions\nInform your physician about any heart, liver, or thyroid conditions before starting therapy.\nNot recommended during pregnancy or breastfeeding unless medically advised.\nAvoid exposure to tobacco smoke or environmental irritants.\nRegular lung function monitoring is recommended for long-term users.\nStorage Instructions\nStore below 30 °C, in a cool, dry place away from direct sunlight.\nKeep the inhaler tightly closed and out of reach of children.\nDo not use after the expiry date printed on the label.\nWhy Choose INH AIRFLOW MAX F250\nDeveloped by Steris Healthcare Pvt. Ltd., a trusted leader in respiratory care.\nCombines proven molecules for optimized asthma and COPD management.\nEnsures consistent dosing accuracy and ease of use.\nBacked by clinical reliability and patient-focused innovation.", "price": 407.0, "discountamount": 121.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2191, "imageuri": "https://productimages.withfloats.com/actual/68fccc7dcb017944361cd570.png", "tileimageuri": "https://productimages.withfloats.com/tile/68fccc7dcb017944361cd570.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-25T12:15:13.774Z", "updatedon": "2026-03-14T08:47:40.851Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//formoterol-fluticasone-inhaler/2191", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "INH AIRFLOW MAX F250", "category": "ASTHMA RANGE", "tags": [ "INH AIRFLOW MAX F250", "Formoterol (6 mcg) and Fluticasone (250 mcg)", "asthma and chronic obstructive pulmonary disease (COPD)", "Controls chronic respiratory symptoms", "formoterol fluticasone inhaler", "formoterol fluticasone inhaler", "formoterol and fluticasone inhaler uses", "fluticasone formoterol inhaler combination", "formoterol fluticasone inhaler for asthma", "formoterol fluticasone inhaler dosage", "what is formoterol fluticasone inhaler used for", "how does formoterol fluticasone inhaler work", "when to use formoterol fluticasone inhaler", "formoterol fluticasone inhaler benefits", "formoterol fluticasone inhaler side effects", "formoterol fluticasone inhaler for asthma control", "formoterol fluticasone inhaler for copd", "best formoterol fluticasone inhaler brand", "formoterol fluticasone inhaler price in india", "buy formoterol fluticasone inhaler online" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662e74687f0960e14a2d95a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Gefitinib 250mg", "description": "\n\nGEFISTERIS 250 is a premium pharmaceutical formulation containing Gefitinib 250mg, a breakthrough targeted therapy medication manufactured by Steris Healthcare. This innovative oral medication represents a significant advancement in the treatment of non-small cell lung cancer (NSCLC), offering patients a precise, scientifically-designed approach to combating one of the world's most challenging malignancies. GEFISTERIS 250 is specifically engineered to target the underlying molecular mechanisms that drive certain types of lung cancer, providing hope and extended survival for patients who carry specific genetic mutations.\nAs a tyrosine kinase inhibitor, GEFISTERIS 250 works at the cellular level to interrupt the signals that tell cancer cells to grow and divide. This targeted approach differs fundamentally from traditional chemotherapy, which affects both healthy and cancerous cells. By focusing specifically on cancer cells with epidermal growth factor receptor (EGFR) mutations, GEFISTERIS 250 offers a more refined treatment strategy with potentially fewer systemic side effects and improved quality of life during treatment.\nUnderstanding Gefitinib 250mg: The Science Behind GEFISTERIS 250\nGefitinib 250mg, the active pharmaceutical ingredient in GEFISTERIS 250, belongs to a revolutionary class of medications known as epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). The development of this medication marked a paradigm shift in oncology, moving from one-size-fits-all chemotherapy approaches to personalized, mutation-specific treatments.\nThe EGFR protein is found on the surface of cells and plays a crucial role in cell growth and division. In normal cells, EGFR activation is carefully regulated. However, in certain lung cancers, mutations in the EGFR gene cause the receptor to remain constantly active, sending continuous signals for the cell to grow, divide, and survive—leading to uncontrolled cancer growth. GEFISTERIS 250 works by blocking the tyrosine kinase activity of the mutated EGFR protein, effectively turning off the growth signal and causing cancer cells to stop proliferating and eventually die.\nThis precision targeting is what makes GEFISTERIS 250 particularly effective for patients whose tumors harbor activating EGFR mutations, particularly the common exon 19 deletions or exon 21 L858R substitution mutations. Before initiating treatment with GEFISTERIS 250, patients undergo molecular testing to confirm the presence of these mutations, ensuring that the therapy is appropriately matched to their specific cancer biology.\nPrimary Uses and Indications of GEFISTERIS 250\nGEFISTERIS 250 is primarily indicated for the treatment of adult patients with metastatic non-small cell lung cancer whose tumors have specific EGFR mutations. The medication is approved for both first-line treatment in newly diagnosed patients and for those whose disease has progressed after platinum-based chemotherapy.\nFirst-Line Treatment: When EGFR mutations are detected in treatment-naïve patients, GEFISTERIS 250 offers an excellent first-line option, often providing superior progression-free survival compared to traditional chemotherapy regimens. Patients starting with targeted therapy typically experience better tolerability and quality of life during initial treatment phases.\nSecond-Line and Beyond: For patients whose cancer has progressed after chemotherapy, GEFISTERIS 250 provides an effective alternative treatment option, particularly when EGFR mutation testing was not performed initially or when the mutation status was unknown at the time of first treatment.\nThe medication is taken orally as a once-daily tablet, offering significant convenience compared to intravenous chemotherapy that requires hospital visits and lengthy infusion times. This oral administration allows patients to maintain greater independence and normalcy in their daily lives while receiving effective cancer treatment.\nKey Benefits of GEFISTERIS 250\n1. Targeted Cancer Fighting Action\nThe primary benefit of GEFISTERIS 250 lies in its precision targeting mechanism. Unlike conventional chemotherapy that attacks all rapidly dividing cells in the body, GEFISTERIS 250 specifically targets cancer cells bearing EGFR mutations. This selective action means that healthy cells are largely spared, resulting in a more favorable side effect profile and better preservation of normal bodily functions during treatment.\n2. Superior Efficacy in EGFR-Mutant NSCLC\nClinical trials have consistently demonstrated that GEFISTERIS 250 and other EGFR-TKIs provide superior progression-free survival compared to chemotherapy in patients with EGFR-mutant NSCLC. Response rates typically range from 60-80% in appropriate patient populations, with many patients experiencing significant tumor shrinkage and symptomatic improvement within weeks of starting treatment.\n3. Improved Quality of Life\nPatients taking GEFISTERIS 250 often report better quality of life compared to those receiving traditional chemotherapy. The medication's targeted nature results in fewer debilitating side effects such as severe nausea, hair loss, and profound fatigue. Many patients can continue working, traveling, and engaging in normal daily activities while on treatment.\n4. Convenient Oral Administration\nGEFISTERIS 250's once-daily oral dosing eliminates the need for frequent hospital visits for intravenous chemotherapy infusions. Patients take one tablet daily at home, providing tremendous convenience and reducing the burden of treatment. This ease of administration contributes significantly to treatment adherence and patient satisfaction.\n5. Rapid Symptom Relief\nMany patients experience rapid improvement in cancer-related symptoms such as cough, shortness of breath, chest pain, and fatigue within the first few weeks of GEFISTERIS 250 treatment. This quick symptomatic relief can dramatically improve quality of life even before significant tumor shrinkage is visible on imaging studies.\n6. Extended Survival Benefits\nLong-term data demonstrates that appropriate use of EGFR-TKIs like GEFISTERIS 250 contributes to extended overall survival in patients with EGFR-mutant lung cancer. When used as part of a comprehensive treatment strategy, including potential sequential therapies after progression, patients can achieve survival times that were unimaginable before the advent of targeted therapies.\n7. Manageable Side Effect Profile\nWhile GEFISTERIS 250 does cause side effects, they are generally more manageable than those associated with traditional chemotherapy. Most side effects can be effectively controlled with supportive medications, dose modifications, or temporary treatment interruptions, allowing patients to continue benefiting from therapy.\n8. Quality Manufacturing by Steris Healthcare\nGEFISTERIS 250 benefits from Steris Healthcare's commitment to pharmaceutical excellence. Each tablet undergoes rigorous quality testing to ensure consistent potency, purity, and bioavailability. This quality assurance means patients receive reliable, effective medication with every dose.\nSide Effects of GEFISTERIS 250 (Gefitinib 250mg)\nWhile GEFISTERIS 250 offers significant therapeutic benefits, patients should be aware of potential side effects. Understanding these effects enables early recognition and appropriate management.\nCommon Side Effects (Affecting 20% or More of Patients):\nSkin Reactions: The most characteristic side effect of GEFISTERIS 250 is an acne-like rash, typically appearing on the face, chest, and back within the first few weeks of treatment. This rash, while cosmetically concerning for some patients, actually correlates with better treatment response. The rash can be managed with topical antibiotics, moisturizers, and sun protection. In severe cases, temporary dose reduction may be necessary.\nDiarrhea: Approximately 50-60% of patients experience diarrhea of varying severity. Mild diarrhea can often be managed with dietary modifications and over-the-counter anti-diarrheal medications like loperamide. Patients should stay well-hydrated and contact their healthcare provider if diarrhea becomes severe or persistent, as dose adjustments may be needed.\nNail Changes: Some patients develop paronychia (nail bed inflammation) or other nail abnormalities. Proper nail care, avoiding trauma to the nail beds, and wearing protective gloves during housework can help minimize these effects.\nDry Skin: Many patients experience skin dryness and itching. Regular use of fragrance-free moisturizers, gentle cleansers, and avoidance of hot showers can help manage these symptoms.\nMouth Sores: Oral mucositis or stomatitis can develop in some patients. Good oral hygiene, avoiding spicy or acidic foods, and using alcohol-free mouthwashes can provide relief.\nLess Common but Serious Side Effects:\nInterstitial Lung Disease (ILD): While rare (1-2% of patients), ILD is the most serious potential side effect of GEFISTERIS 250. Symptoms include sudden onset or worsening of respiratory symptoms such as difficulty breathing, cough, or fever. This requires immediate medical attention and usually necessitates permanent discontinuation of the medication.\nLiver Function Abnormalities: Elevated liver enzymes can occur, requiring regular monitoring through blood tests. Most cases are asymptomatic and reversible with dose modification or temporary discontinuation.\nEye Problems: Dry eyes, corneal erosion, or other ocular issues may develop. Regular use of lubricating eye drops and ophthalmological evaluation when symptoms occur can prevent serious complications.\nGastrointestinal Perforation: Though rare, serious gastrointestinal complications including perforation can occur, particularly in patients with underlying GI conditions.\nManagement Strategies:\nMost side effects can be effectively managed through:\n\nProactive supportive care and prophylactic measures\nDose modifications (reduction to 250mg every other day in some cases)\nTemporary treatment interruptions allowing recovery\nSymptomatic treatment with appropriate medications\nPatient education about early recognition and reporting of symptoms\n\nPatients should maintain open communication with their healthcare team, reporting any new or worsening symptoms promptly. Regular monitoring through clinical visits and laboratory testing helps identify and address side effects before they become serious.\nDosage and Administration Guidelines\nThe standard dose of GEFISTERIS 250 is one 250mg tablet taken orally once daily, with or without food. The tablet should be swallowed whole with water and should not be crushed or chewed. If a dose is missed and it's been less than 12 hours since the scheduled time, patients should take the missed dose. If more than 12 hours have passed, skip the missed dose and resume the regular schedule—never double up on doses.\nTreatment continues until disease progression or unacceptable toxicity occurs. Some patients remain on GEFISTERIS 250 for months or even years if they continue to benefit without prohibitive side effects. Dose modifications may be necessary based on individual tolerance, typically reducing the frequency to every other day rather than lowering the individual dose.\nPrecautions and Important Considerations\nPatients taking GEFISTERIS 250 should be aware of several important precautions. The medication can cause harm to developing fetuses, so women of childbearing potential must use effective contraception during treatment and for at least two weeks after the last dose. Breastfeeding should be avoided during treatment and for two weeks after completion.\nGEFISTERIS 250 can interact with medications that affect stomach acid, including proton pump inhibitors and H2-receptor antagonists. If antacids are needed, they should be taken several hours apart from GEFISTERIS 250. The medication may also interact with certain other drugs metabolized by the liver, so patients should inform their healthcare provider about all medications, supplements, and herbal products they're taking.\nRegular monitoring is essential during GEFISTERIS 250 treatment, including periodic liver function tests, pulmonary symptom assessment, and clinical evaluation for skin and other toxicities. Patients should avoid prolonged sun exposure and use high-SPF sunscreen, as the medication can increase photosensitivity.\nConclusion\nGEFISTERIS 250 represents a transformative treatment option for patients with EGFR-mutant non-small cell lung cancer, offering targeted, effective therapy with a manageable side effect profile. Manufactured by Steris Healthcare with unwavering commitment to quality and patient outcomes, GEFISTERIS 250 delivers Gefitinib 250mg in a formulation designed for optimal bioavailability and consistent therapeutic effect.\nThe medication's precision targeting of cancer-driving mutations, combined with convenient oral administration and generally tolerable side effects, makes GEFISTERIS 250 an excellent choice for eligible patients. While side effects do occur and require monitoring and management, the potential benefits—including tumor response, symptom improvement, extended progression-free survival, and enhanced quality of life—often significantly outweigh the risks for appropriately selected patients.\nSuccess with GEFISTERIS 250 requires partnership between patients and their healthcare teams. Molecular testing to confirm EGFR mutation status before treatment, adherence to the prescribed regimen, proactive management of side effects, and regular monitoring all contribute to optimal outcomes. For many patients with EGFR-mutant lung cancer, GEFISTERIS 250 offers not just treatment, but genuine hope for extended, quality life.\nAs personalized medicine continues to evolve, medications like GEFISTERIS 250 exemplify the power of matching treatments to individual tumor characteristics. Steris Healthcare's commitment to delivering this advanced therapy with assured quality and accessibility ensures that more patients can benefit from the remarkable advances in targeted cancer treatment that Gefitinib 250mg represents.\n", "price": 2760.0, "discountamount": 828.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "Call", "Uses", "Rash", "Note", "NSCLC", "Email", "nausea", "Dosage", "spread", "WhatsApp", "diarrhea", "Gefitinib", "treatment", "One tablet", "GEFISTERIS", "information", "sterispharma", "consultation", "sterisonline", "Side Effects", "cancer cells", "targeted therapy", "Regular monitoring", "healthcare provider", "small cell lung cancer", "healthcare professional", "specific EGFR mutations", "epidermal growth factor receptor", "potential liver function alterations" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1530, "imageuri": "https://productimages.withfloats.com/actual/667d25ffb56721898510e93e.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d25ffb56721898510e93e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T10:56:06.808Z", "updatedon": "2026-04-15T10:04:00.767Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//gefitinib-250mg/1530", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GEFISTERIS 250", "category": "Oncology", "tags": [ "gefitinib 250 mg uses", "gefitinib 250 mg online purchase", "gefitinib 250 mg tablets price in india", "non-small cell lung cancer (NSCLC).", "triggered by chemotherapy.", "cancer biology.", "Superior Efficacy in EGFR-Mutant NSCLC", "gefitinib 250mg", "gefitinib 250mg tablet", "gefitinib 250mg tab", "gefitinib 250 mg tablet uses in lung cancer", "gefitinib tablets 250 mg dosage and benefits", "gefitinib 250 mg price in india", "gefitinib 250 mg EGFR inhibitor for NSCLC treatment india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }

This is your website preview.

Acebrophylline and Erdos

Everolimus Tablets 0.5 m

ambroxol + guaifenesin +

fdc of indacaterol malea

Sodium Chloride Inhalati

Frusemide IP 40mg

Ambrisentan 5mg, Tadalaf

formoterol fluticasone i

Gefitinib 250mg

Still searching for
enhanced lung function?

Still searching for
enhanced lung function?

Opening Hours

Subscribe to our newsletter!

Social share

This is your website preview.